Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
1.470
-0.140 (-8.70%)
At close: Nov 20, 2024, 4:00 PM
1.480
+0.010 (0.68%)
After-hours: Nov 20, 2024, 7:38 PM EST
Akari Therapeutics, Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -20.16 | -10.01 | -17.75 | -17.42 | -17.08 | -16.85 | |
| Depreciation & Amortization | 0.01 | 0 | 0 | 0 | 0.01 | 0.02 | |
| Stock-Based Compensation | 1.29 | 1.15 | 0.74 | 0.31 | 0.33 | 1.05 | |
| Other Operating Activities | -1.18 | -6.71 | -5.32 | 0.24 | -0.15 | -0.23 | |
| Change in Accounts Payable | 3.78 | -0.94 | -0.88 | -0.24 | -0.25 | 2.38 | |
| Change in Other Net Operating Assets | 1.41 | 0.07 | 1.7 | -1.74 | 0.19 | 0.71 | |
| Operating Cash Flow | -14.84 | -16.43 | -21.5 | -18.85 | -16.95 | -12.92 | |
| Total Debt Issued | 1.03 | - | - | - | - | - | |
| Total Debt Repaid | -0.88 | - | - | - | - | - | |
| Net Debt Issued (Repaid) | 0.15 | - | - | - | - | - | |
| Issuance of Common Stock | 12.21 | 7.02 | 25.29 | 14.29 | 25.07 | 12.65 | |
| Financing Cash Flow | 12.35 | 7.02 | 25.29 | 14.29 | 25.07 | 12.65 | |
| Foreign Exchange Rate Adjustments | 0 | 0.01 | 0.11 | -0.14 | 0.2 | 0.03 | |
| Net Cash Flow | -2.49 | -9.41 | 3.89 | -4.69 | 8.32 | -0.24 | |
| Free Cash Flow | -14.84 | -16.43 | -21.5 | -18.85 | -16.95 | -12.92 | |
| Free Cash Flow Per Share | -1.81 | -3.36 | -6.89 | -8.78 | -10.73 | -14.11 | |
| Levered Free Cash Flow | -5.96 | -16.74 | -6.04 | -11.31 | -11.96 | -6.69 | |
| Unlevered Free Cash Flow | -5.89 | -16.74 | -6.04 | -11.31 | -11.96 | -6.69 | |
| Change in Net Working Capital | -3.85 | 7.39 | -7.65 | 0.87 | 1.06 | -2.85 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.